aware of this. Moreover, there is a level of subjectivity in their conclusions, as the nature of each individual piece of data in-andof-itself, can be confounding. For instance, the breakdown of Hox clustering has been observed in several bilaterian groups [4, 5, 10] and in the tunicate Oikopleura the Hox cluster has diverged so dramatically that none of its Hox genes are linked [3] ; yet, all of these animals show high axial complexity and a similar Hox gene expression pattern along the body axis. Moreover, the difficulty in assigning strict Hox classes to the cnidarian Hox genes could be a result of the very old age of this lineage as well as the vagaries of using the short homeodomains (60 amino acids) for phylogenetic inference [11] . Differences in the Hox repertoire between Nematostella and Eleutheria could be significant, but a similar situation has been seen in tunicates, between Ciona and Oikopleura [3] . And with respect to the expression patterns, while we should be able to recognize when colinear patterns exist, the very deep divergence time of the cnidarian lineage may have wiped out their vestiges. Differences in expression pattern seen amongst the different taxa for the same Hox gene have also been observed in bilaterians such as fishes [12] . Finally, might the cnidarian Hox repertoire have been used in a non-colinear fashion in the myriad morphological differences seen in the group, equivalent to the stunning innovations involving Hox gene expression that were observed in a cephalopod [13] ? The conclusions by Kamm et al. [8] are of course strongest when the data are considered as a whole, and are certainly thought-provoking. It will be of extreme interest to see how well their conclusions hold up as genomes of other cnidarians and primitive metazoans such as sponges, placozoans and acoel flatworms are examined and sequenced. (CRAC) channel function has been identified through independent genome-wide screens. This huge advance will enable molecular dissection of the CRAC channel complex, moving the field beyond ICRAC signature to structure.
Lisbeth C. Robinson and Jonathan S. Marchant
In the years since the phenomenon of intracellular Ca 2+ store-operated Ca 2+ entry was first proposed, two black boxes have frustrated researchers: the molecular identity of the store-operated channels (SOCs) that mediate Ca 2+ entry in response to Ca 2+ store depletion, and the mechanism by which Ca 2+ store depletion is communicated to these elusive SOCs at the cell surface (reviewed in [1] [2] [3] [4] [5] store depletion to SOC activation [6, 7] . Now, two research groups [8, 9] have independently converged upon a novel transmembrane protein essential for the function of the best defined SOC -the Ca 2+ -release activated Ca 2+ (CRAC) channel that has been electrophysiologically well-characterized in T cells and several other cell types [3, 4] . Whether this new protein proves to be the entire CRAC channel itself, an essential subunit or an obligate cell-surface regulator, the long search for a molecular identity underpinning ICRAC is over.
The major catalyst for both of these developments has been the application of genome-wide RNA interference (RNAi) screening, performed mostly in Drosophila cell lines [6, 8, 9] using available libraries that capitalize on the robustness of RNAi effected by long dsRNAs and the lower redundancy of the Drosophila genome relative to mammalian models. In a doublet of Nature papers from Anjana Rao's group [8, 10] , this RNAi screening approach was executed in parallel with another screen -a more classical linkage analysis -in a pedigree harbouring two siblings with a rare, hereditary severe combined immunodeficiency (SCID), which in these specific patients has been attributed to an absence of ICRAC [11] [12] [13] . Single nucleotide polymorphism (SNP) mapping analysis of SCID family members first delimited six genomic regions, subsequently refined to a single, multigenic stretch containing a human homologue of a candidate also identified in the Drosophila RNAi screen. This synergistic convergence of two unbiased, genome-wide screens -in humans and flies -to identify a novel gene that, first, is naturally mutated in the SCID pedigree, and, second, complements the SOC influx and ICRAC deficit in SCID T-cell lines, represents a truly comprehensive body of work spanning bench-to-bedside.
Gwack et al. [10] detail the results of the RNAi screens, in which defects in resting localization of a GFP-tagged NFAT1 construct, as well as nuclear shuttling of the same construct in thapsigarginstimulated cells were scored. This was an audacious approach given the absence of the Ca 2+ -dependent NFAT family members (NFAT1-4) in invertebrates [14] . However, functional conservation of other key components of this signalling pathway in Drosophila (an ICRAC-like current [15] , calcineurin and other NFAT maintenance/ export kinases [10] ) ensured that the sustained Ca 2+ influx signal evoked by Ca 2+ store depletion triggered dephosphorylation and nuclear translocation of the vertebrate NFAT reporter [8] , recapitulating the membraneto-nucleus signaling pathway impaired in the SCID T cells. A variety of candidates (w1 in 40 tested dsRNAs), spanning the expected and unexpected, emerged from these assays and Rao's group have initially focused on results stemming from two Drosophila gene 'hits': olf186-F, the gene essential for store-operated Ca 2+ entry [8] and CG40478, a member of the DYRK family of dual-specificity protein kinases, now revealed as novel regulators of NFAT shuttling ( [10] , see also [16] ). While this commentary focuses on the former discovery, it would be remiss not to highlight recent data linking developmental facets of Down's syndrome to altered NFAT nuclear residency mediated by increased levels of DYRK1A [16] . Clearly, this proved a very informative RNAi screen.
The Drosophila gene olf186-F has three human homologues, one of which (FLJ14466, see nomenclature [17] ) localized within the genomic region delimited by the SCID linkage analysis. DNA sequencing revealed that two identical missense mutations in FLJ14466 were harboured in this specific SCID pedigree, and two copies of the mutated allele were inherited by the afflicted brothers [8] . Feske et al. [8] christened the members of this novel gene family ORAI1, ORAI2 and ORAI3 after the Homeric Hours (Urai, [18] ), guardians of the gates of heaven, who regulated passage between heaven and Olympus, and the earth below. ORAI1 (FLJ14466) encodes a w300 amino-acid protein (Orai1) containing four predicted transmembrane domains separating cytoplasmic amino and catboxyl termini. The SCID mutation (resulting in an arginine to tryptophan substitution, R91W) lies at the start of the first predicted transmembrane domain, impairing ICRAC function, but not targeting of Orai1 to the cell surface [8] -bound calmodulin activates calcineurin to dephosphorylate NFAT (black, dephosphorylated form) and expose a nuclear localization sequence (NLS). Sustained Ca 2+ influx mediated by ICRAC is necessary to effect a prolonged NFAT translocation that regulates genes crucial for Tcell activation [12] . NFAT shuttling is also controlled by a variety of 'maintenance' kinases (e.g. casein kinase 1, CK1), which phosphorylate NFAT at multiple sites (red, phosphorylated form) to keep it in the cytoplasm, and 'export' kinases (e.g. CK1 and glycogen synthase kinase 3, GSK3), which rephosphorylate nuclear NFAT to terminate gene transcription and expose a nuclear export signal (NES). Gwack et al. [10] identify the DYRK-family kinases as new regulators of NFAT shuttling (see also [16] ), functioning as both export (DYRK1A) and maintenance (DYRK2) kinases that phosphorylate the NFAT serine-rich SP-3 motif.
a Ca 2+ current with the electrophysiological and pharmacological signature of ICRAC [8, 13] . Independently, Vig et al. [9] also identified olf186-F from a high throughput Ca 2+ imaging-based RNAi screen, again in Drosophila S2R+ cells. Their data underscore the conclusions of the study described above, but additionally demonstrate the effects of manipulating Orai1 levels (named CRACM1 in [9] ) in various cell lines. Their electrophysiological measurements show that siRNA-mediated silencing of endogenous Orai1 abolishes ICRAC, but Orai1 overexpression does not potentiate ICRAC amplitude.
It is not surprising that mutational ablation of ICRAC in T cells results in impaired immunocompetency. CRAC channels probably constitute the sole route for Ca 2+ entry in T cells following antigen stimulation of the T-cell receptor [19] , and the resultant sustained Ca 2+ entry signals are crucial for regulating gene expression integral to T-cell activation ( [12] , see Figure 1 ). However, it is worth commenting on the observations that, first, heterozygote carriers of the R91W mutation are disease-free (impairment in Ca 2+ -store dependent Ca 2+ influx was demonstrable experimentally only under hypocalcemic conditions, [8] ) and, second, that the mutation precipitates a specific cellular/ tissue pathology (despite the widespread distribution of ORAI1 mRNA [8] ). Ultimately, both observations underscore the importance of expression level ('dosage'), in addition to functional redundancy in Ca 2+ entry mechanisms ('diversity') in disease progression. That functional heterozygosity does not manifest T-cell dysfunction implies reserve capacity for ICRAC functionality in T-cell behaviour (normally >5000 active CRAC channels per cell [19] ). Moreover, in other cell types in these patients, where ICRAC density is even lower [9] , yet presumably critical for specific cellular activities, other mechanisms -perhaps expression of Orai2/Orai3 -must complement the ICRAC deficit associated with Orai1[R91W], since the clinical presentation of the SCID brothers is predominantly one of immunodeficiency. Whatever the basis for this redundancy, the fact that loss of Orai1 function proved embryonically non-lethal was crucial to the success of this entire approach.
Discovery of the role of this novel gene family is a major leap forward for the Ca 2+ signalling community [8, 9] . ORAI1 is annotated in the genomes of a variety of organisms that have agonist-releasable intracellular Ca 2+ stores, and its sequence is well conserved. With the identification of Orai1, molecular dissection of its role in the CRAC channel complex can begin. Does Orai1 singularly constitute the CRAC channel or does it act as an obligate subunit of a heteromeric assembly with other proteins? Perhaps Orai2 and/or Orai3, which share >70% amino acid equivalency with Orai1, fulfill this role. Or, to take the strictest analogy with the mythological Urai, does Orai1 act as a discrete, yet essential, regulator (gatekeeper) of CRAC channel (the gate itself)? What about the relationship between Orai1 and STIM [6, 7] ? Live cell imaging data using evanescent wave microscopy correlates juxtamembrane puncta of translocated STIM1 with focal sites of Ca 2+ entry resulting from CRAC channel activity [20] . Consequently, extrapolation of these new data [8, 9] would predict Orai1 to be resident and locally activated within these zones. As these exciting new data strengthen our molecular grasp onto ICRAC [6] [7] [8] [9] , answers to all these questions cannot be far away.
